Zhi Liu

This inventor holds 19 USPTO granted patents and 8 published patent applications, plus 2 CIPO patents and 7 EPO patents, primarily in Biopharmaceutical Engineering. Top assignees: University of Washington, Amgen Inc., Qilu Puget Sound Biotherapeutics Corporation. Active years: 2004-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhi Liu. Retrieved from https://idiyas.com/inventor/zhi-liu-z0p1f5fe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 19 (Patent Applications = 8)

% Patents Active = 52.6

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 7 (Patent Applications = 13)

Average Co-Inventor Count = 3.3

ph-index = 7

Forward Citations = 135(Granted Patents)

Location History:

West Roxbury, MA (US) (2004)
Mundelein, IL (US) (2013)
Seattle, WA (US) (2006 - 2017)
Shoreline, WA (US) (2017 - 2024)

Company Filing History:

6 out of 2,173

University of Washington

Qilu Puget Sound Biotherapeutics Corporation

Years Active: 2004-2026

Loading Chart...

Areas of Expertise:

Anti-PD1 Antibodies

Heterodimeric Immunoglobulins

Fc Variants

Bispecific Antibodies

HSV-specific T-lymphocytes

Micronization Methods

Fusion Proteins

ErbB4 Selectivity

Antibody Mixtures

Rapid Purification

Anti-CCR8 Antibodies

Hydrophobic Drugs

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12729229 - ENGINEERED NRG-1 VARIANTS WITH IMPROVED SELECTIVITY TOWARD ErbB4 BUT NOT AGAINST ErbB3 (2026-09-08),

2. 12655223 - ANTI-CCR8 ANTIBODIES (2026-06-16),

3. 12441816 - Heterodimeric Fc for making fusion proteins and bispecific antibodies (2025-10-14),

4. 12037397 - Anti-PD1 and anti-CTLA4 antibodies (2024-07-16),

5. 11466078 - Heterodimeric immunoglobulins (2022-10-11),

6. 11198732 - Fc variants (2021-12-14),

7. 11130808 - Mixtures of antibodies (2021-09-28),

8. 11124570 - Anti-PD1 and anti-CTLA4 antibodies (2021-09-21),

9. 10233237 - Heterodimeric immunoglobulins (2019-03-19),

10. 9822173 - Heterodimeric immunoglobulins (2017-11-21),

11. 9675688 - Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same (2017-06-13),

12. 9138473 - Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same (2015-09-22),

13. 8524829 - Methods for micronization of hydrophobic drugs (2013-09-03),

14. 8197824 - Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same (2012-06-12),

15. 7666434 - Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same (2010-02-23),

Title: The Innovative Journey of Zhi Liu

Introduction: Zhi Liu, a talented inventor based in Seattle, WA, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Zhi Liu holds several patents in the areas of artificial intelligence, machine learning, and robotics. His most recent patent focuses on developing a cutting-edge algorithm for autonomous vehicles to enhance safety and efficiency on the roads.

Career Highlights: With a background in computer science and engineering, Zhi Liu has a successful career working for leading tech companies in the Seattle area. He has been instrumental in developing innovative solutions that have revolutionized the industry.

Collaborations: Zhi Liu has collaborated with top researchers and engineers from renowned universities and research institutions to further advance his inventions. His collaborative efforts have led to the creation of groundbreaking technologies that have had a lasting impact.

Conclusion: Zhi Liu's passion for innovation and his dedication to pushing the boundaries of technology have established him as a prominent figure in the world of inventions. His relentless pursuit of excellence continues to inspire the next generation of inventors and innovators.

Profile summary based on public USPTO records.